Paper published in Neurology

Our paper TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis has been accepted for publication in Neurology.

Neurology2013

Publicat dins de Scientific publications | Etiquetat com a , , , , | Deixa un comentari

Publication at Revista Española de Cardiología

rec2013-corBarrabés JA, Figueras J, Candell-Riera J, Agulló L, Inserte J, Garcia-Dorado D. Distension of the ischemic region predicts increased ventricular fibrillation inducibility following coronary occlusion in swine. Rev Esp Cardiol (Engl Ed). 2013 Mar;66(3):171-6.

REC2013

Publicat dins de Scientific publications | Etiquetat com a , , , | Deixa un comentari

ECTRIMS 2012 (Lyon)

Two posters sent:

ectrims2012-p765
Costa C, Canto E, Wing AC, Agullo L, Montalban X, Comabella M. CHI3L1 expression in chronic active multiple sclerosis lesions. Mult. Scler. J. 2012; 18:342-342.

ectrims2012-p802
Comabella M, Caminero AB, Malhotra S, Agullo L, Reverter F, et al. Study of the TNFRSF1A polymorphisms rs4149584 and rs1800693 in patients with multiple sclerosis. Mult. Scler. J. 2012; 18:60-361.

Publicat dins de Scientific meetings | Etiquetat com a , , , , | Deixa un comentari

Award Joan Oró for Scientific Communication

Ignasi Buch & Inés Navarro, Barcelona 2011.

Publicat dins de Sciencific news | Deixa un comentari

Miguel Marín-Padilla at Vall d’Hebron

Today I attended the seminar “The Human Brain, Development and Structure” (El Cerebro Humano, Desarrollo y Estructura) presented by Professor Emeritus Dr. Miguel Marín-Padilla (Department of Pathology, Dartmouth Medical School, Hanover NH, USA) here at Vall d’Hebron Hospital (Neuroscience Seminars). Sincerely, it was probably the most pleasant seminar of the last year. Miguel is able to teach that science is not necessarily joined to complex and expensive techniques. He encourage young researchers to use their minds and innovate. Difficult words nowadays when science has become a pseudo-industrial activity.

One thing is clear. Real skillful scientists are modest.

Publicat dins de Seminars | Deixa un comentari

Jennifer Pérez Boza joins us

Jennifer Pérez Boza has got a grant from the Instituto Carlos III (FIS, Fondo de Investigaciones Sanitarias).

Publicat dins de Laboratory | Deixa un comentari

Participation of our group in a publication in Nature

Dr. Manuel Comabella and Dr. Xavier Montalban from our research group have contributed to the study “Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis” published in Nature this month (Nature 476, 214–219). This is probably the largest genetics study ever undertaken on Multiple Sclerosis and includes contributions from almost 250 researchers as members of the International Multiple Sclerosis Genetics Consortium and the Wellcome Trust Case Control Consortium.

Publicat dins de Scientific publications | Deixa un comentari

LAB Seminar: Ignasi Barba

Yesterday, Dr. Ignasi Barba made an introduction to Metabonomisc in our Lab seminars. Ignasi Barba is member of the Research Group on Cardiovascular Diseases at the same institution where he is in charge of the Metabomics Unit .

Publicat dins de Seminars | Etiquetat com a , , , , | Deixa un comentari

LAB Seminar: Martin Indarte

Next Wednesday, Dr. Martin Indarte will make a presentation in our lab with the title: Computer assisted drug discovery: What can it do for your research?

He is working at the Laboratory of Biologia Computacional i Proteòmica, Institut de Biotecnologia i Biomedicina (IBB), Universitat Autònoma de Barcelona (UAB), directed by Dr. Xavier Daura.


Abstract of the presentation:
“Drug discovery and development are extremely time and resources consuming processes. Computational approaches offer an inexpensive and interesting approach that can expedite drug discovery, design, development and optimization of lead compounds. Commonly used computational approaches include ligand-based drug design (e.g. pharmacophore searches), structure-based drug design (docking), homology modeling and quantitative structure-activity and quantitative structure-property relationships (QSAR/QSPR). These approaches can also guide site directed mutagenesis, shed some light on protein behavior, peptide binding and molecular recognition phenomena. In this talk, several first hand examples of successful interactions between molecular modeling, molecular biology and pharmacology will be covered with the aim of improving positive interactions between experimentalists and molecular modelers. If you ever wondered what is all the fuzz about molecular modelers and how they could help your research, this talk is for you.”

Publicat dins de Seminars | Deixa un comentari

Additional hours for the TNF project at BSC

We have obtained 20,000 additional hours for the TNF project at BSC.

Publicat dins de Scientific projects | Deixa un comentari